These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 29479765)

  • 21. Adjunctive lacosamide for focal epilepsy: an open-label trial evaluating the impact of flexible titration and dosing on safety and seizure outcomes.
    Baulac M; Coulbaut S; Doty P; McShea C; De Backer M; Bartolomei F; Vlaicu M
    Epileptic Disord; 2017 Jun; 19(2):186-194. PubMed ID: 28597842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and Tolerability of Lacosamide for Focal Epileptic Patients: Study from Epilepsy Clinic in Makkah.
    Alkhotani A; Abualula H; Almatrafi Y; Ghomiem S; Alaa A
    CNS Neurol Disord Drug Targets; 2021; 20(1):87-97. PubMed ID: 32814542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trial.
    Biton V; Berkovic SF; Abou-Khalil B; Sperling MR; Johnson ME; Lu S
    Epilepsia; 2014 Jan; 55(1):57-66. PubMed ID: 24446953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and efficacy of adjunctive lacosamide in Chinese and Japanese adults with epilepsy and focal seizures: A long-term, open-label extension of a randomized, controlled trial.
    Inoue Y; Liao W; Wang X; Du X; Tennigkeit F; Sasamoto H; Osakabe T; Hoshii N; Yuen N; Hong Z
    Epilepsy Res; 2021 Oct; 176():106705. PubMed ID: 34246118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analyses of seizure responses supportive of a novel trial design to assess efficacy of antiepileptic drugs in infants and young children with epilepsy: Post hoc analyses of pediatric levetiracetam and lacosamide trials.
    Johnson ME; McClung C; Bozorg AM
    Epilepsia Open; 2021 Jun; 6(2):359-368. PubMed ID: 34033237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and tolerability of treatment with lacosamide: Postmarketing experience from the Middle East region.
    Arabi M; Alsaadi T; Nasreddine W; Al-Hashel J; Dirani M; Beydoun A
    Epilepsy Behav; 2018 Jul; 84():118-121. PubMed ID: 29778846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and tolerability of adjunctive lacosamide in a pediatric population with focal seizures - An open-label trial.
    Ferreira JA; Le Pichon JB; Abdelmoity AT; Dilley D; Dedeken P; Daniels T; Byrnes W
    Seizure; 2019 Oct; 71():166-173. PubMed ID: 31374487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The efficacy of lacosamide in relation to antiepileptic drug history. Clinical experiences in adult partial epilepsy].
    Barcs Gábor ; Szűcs A; Horváth A; Kamondi A
    Ideggyogy Sz; 2015 Jan; 68(1-2):23-9. PubMed ID: 25842913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical impact of the dose and blood concentration of lacosamide in Japanese pediatric patients with epilepsy: A cohort study.
    Ishikawa N; Eguchi Y; Izumo H; Tateishi Y; Tani H; Kobayashi Y; Okada S
    Epilepsy Behav; 2022 Apr; 129():108614. PubMed ID: 35203014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of lacosamide as adjunctive therapy in children with refractory epilepsy.
    Yorns WR; Khurana DS; Carvalho KS; Hardison HH; Legido A; Valencia I
    J Child Neurol; 2014 Jan; 29(1):23-7. PubMed ID: 23143718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: results from a double-blind, randomized, placebo-controlled trial.
    Ryvlin P; Werhahn KJ; Blaszczyk B; Johnson ME; Lu S
    Epilepsia; 2014 Jan; 55(1):47-56. PubMed ID: 24256083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tolerability and efficacy of lacosamide and controlled-release carbamazepine monotherapy in patients with newly diagnosed epilepsy and concomitant psychiatric conditions: Post hoc analysis of a prospective, randomized, double-blind trial.
    Schmitz B; Dimova S; Zhang Y; Chellun D; De Backer M; Gasalla T
    Epilepsy Res; 2020 Jan; 159():106220. PubMed ID: 31812127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A long-term noninterventional safety study of adjunctive lacosamide therapy in patients with epilepsy and uncontrolled partial-onset seizures.
    Steinhoff BJ; Eckhardt K; Doty P; De Backer M; Brunnert M; Schulze-Bonhage A
    Epilepsy Behav; 2016 May; 58():35-43. PubMed ID: 27054272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Control of seizures in different stages of partial epilepsy: LACO-EXP, a Spanish retrospective study of lacosamide.
    Villanueva V; López FJ; Serratosa JM; González-Giraldez B; Campos D; Molins A; Rodriguez Uranga J; Mauri JA; Salas-Puig J; Toledo M; Sánchez-Alvarez JC; Moreno A; Serrano-Castro PJ; Saiz-Diaz RA; González de la Aleja J; de la Peña P; Asensio M
    Epilepsy Behav; 2013 Nov; 29(2):349-56. PubMed ID: 23999191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of observational studies in supporting extrapolation of efficacy data from adults to children with epilepsy - A systematic review of the literature using lacosamide as an example.
    Arzimanoglou A; Kalilani L; Anamoo MA; Cooney M; Golembesky A; Taeter C; Bozorg A; Tofighy A; Wheless J
    Eur J Paediatr Neurol; 2019 Jul; 23(4):589-603. PubMed ID: 31171490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term efficacy of add-on lacosamide treatment in children and adolescents with refractory epilepsies: A single-center observational study.
    Rosati A; Ilvento L; Rizzi R; Doccini V; Leo MC; Pugi A; De Masi S; Guerrini R
    Epilepsia; 2018 May; 59(5):1004-1010. PubMed ID: 29663335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experience with lacosamide in a series of children with drug-resistant focal epilepsy.
    Guilhoto LM; Loddenkemper T; Gooty VD; Rotenberg A; Takeoka M; Duffy FH; Coulter D; Urion D; Bourgeois BF; Kothare SV
    Pediatr Neurol; 2011 Jun; 44(6):414-9. PubMed ID: 21555051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lacosamide efficacy and tolerability in clinical practice - Post marketing analysis from a single dedicated epilepsy center.
    Baker MD; Abou-Khalil BW; Arain A; Tummala P; Azar NJ; Haas KF; Sonmezturk HH
    Clin Neurol Neurosurg; 2018 Aug; 171():179-183. PubMed ID: 29929174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of adjunctive lacosamide in the treatment of primary generalised tonic-clonic seizures: a double-blind, randomised, placebo-controlled trial.
    Vossler DG; Knake S; O'Brien TJ; Watanabe M; Brock M; Steiniger-Brach B; Williams P; Roebling R;
    J Neurol Neurosurg Psychiatry; 2020 Oct; 91(10):1067-1075. PubMed ID: 32817358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.